← Leaderboards

Javed Khan

Division Of Basic Sciences - Nci

Google Scholar ↗PubMed ↗ORCID ↗

$0

Attributed

$0

Total exposure

0

Grants

0

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at Division Of Basic Sciences - Nci

Same institution · by research overlap

Markku Miettinen$0

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsGenesMalignant Childhood NeoplasmGenomicsProteinsNeuroblastomaHigh RiskMutationTumorRhabdomyosarcomaPathway InteractionsGenomeLeadBiologyMutateDiagnosisPatternTargeted TreatmentSamplingMolecularCellsBiologicalGene Expression ProfilingProteomics

Grant awards (109)

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$1,295,181

ZIA · FY2025 · CA · contact PI

Developing Novel Therapies for High Risk Pediatric Cancers$1,079,318

ZIA · FY2025 · CA · contact PI

Bioinformatics, Machine Learning, Systems Biology of Cancers$1,079,318

ZIA · FY2025 · CA · contact PI

Therapy Resistance Mechanisms for Cancer$647,591

ZIA · FY2025 · CA · contact PI

Predicting Response and Prognosis in Pediatric Cancers$215,864

ZIA · FY2025 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$1,378,435

ZIA · FY2024 · CA · contact PI

Bioinformatics, Machine Learning, Systems Biology of Cancers$1,148,695

ZIA · FY2024 · CA · contact PI

Developing Novel Therapies for High Risk Pediatric Cancers$1,148,695

ZIA · FY2024 · CA · contact PI

Therapy Resistance Mechanisms for Cancer$689,217

ZIA · FY2024 · CA · contact PI

Predicting Response and Prognosis in Pediatric Cancers$229,739

ZIA · FY2024 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$1,107,095

ZIA · FY2023 · CA · contact PI

Developing Novel Therapies for High Risk Pediatric Cancers$922,580

ZIA · FY2023 · CA · contact PI

Bioinformatics, Machine Learning, Systems Biology of Cancers$922,580

ZIA · FY2023 · CA · contact PI

Therapy Resistance Mechanisms for Cancer$553,548

ZIA · FY2023 · CA · contact PI

Predicting Response Prognosis in Pediatric Cancers$184,515

ZIA · FY2023 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$1,025,166

ZIA · FY2022 · CA · contact PI

Bioinformatics: Systems Biology of Cancers$854,306

ZIA · FY2022 · CA · contact PI

Developing Novel Therapies for High Risk Pediatric Cancers$854,306

ZIA · FY2022 · CA · contact PI

Novel Mutations and Therapy Resistance Mechanisms in Pediatric Cancers$512,584

ZIA · FY2022 · CA · contact PI

Predicting Response Prognosis in Pediatric Cancers$170,862

ZIA · FY2022 · CA · contact PI

Novel Mutations and Therapy Resistance Mechanisms in Pediatric Cancers$906,517

ZIA · FY2021 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$906,517

ZIA · FY2021 · CA · contact PI

Bioinformatics: Systems Biology of Cancers$604,344

ZIA · FY2021 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$302,173

ZIA · FY2021 · CA · contact PI

Predicting Response Prognosis in Pediatric Cancers$302,173

ZIA · FY2021 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$951,608

ZIA · FY2020 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$951,608

ZIA · FY2020 · CA · contact PI

Bioinformatics: Systems Biology of Pediatric Cancers$634,406

ZIA · FY2020 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$317,202

ZIA · FY2020 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$317,202

ZIA · FY2020 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$724,798

ZIA · FY2019 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$724,798

ZIA · FY2019 · CA · contact PI

Bioinformatics: Systems Biology of Pediatric Cancers$483,199

ZIA · FY2019 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$241,599

ZIA · FY2019 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$241,599

ZIA · FY2019 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$742,680

ZIA · FY2018 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$742,680

ZIA · FY2018 · CA · contact PI

Bioinformatics: Systems Biology of Pediatric Cancers$495,121

ZIA · FY2018 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$247,561

ZIA · FY2018 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$247,561

ZIA · FY2018 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$711,607

ZIA · FY2017 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$711,607

ZIA · FY2017 · CA · contact PI

Bioinformatics: Systems Biology of Pediatric Cancers$474,405

ZIA · FY2017 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$237,202

ZIA · FY2017 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$237,202

ZIA · FY2017 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$768,706

ZIA · FY2016 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$768,706

ZIA · FY2016 · CA · contact PI

Bioinformatics: Systems Biology of Pediatric Cancers$512,471

ZIA · FY2016 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$256,235

ZIA · FY2016 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$256,235

ZIA · FY2016 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$751,960

ZIA · FY2015 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$751,960

ZIA · FY2015 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS$501,308

ZIA · FY2015 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$250,654

ZIA · FY2015 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$250,654

ZIA · FY2015 · CA · contact PI

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma$1,128,637

ZIA · FY2014 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$1,128,637

ZIA · FY2014 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS$752,424

ZIA · FY2014 · CA · contact PI

Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma$376,213

ZIA · FY2014 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$376,213

ZIA · FY2014 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$1,326,223

ZIA · FY2013 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$646,939

ZIA · FY2013 · CA · contact PI

Targeting High-risk Neuroblastoma using high through put siRNA screening$485,203

ZIA · FY2013 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$323,469

ZIA · FY2013 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$161,734

ZIA · FY2013 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$129,388

ZIA · FY2013 · CA · contact PI

Comparative Genomic Hybridization of Neuroblastoma$97,041

ZIA · FY2013 · CA · contact PI

Characterization of Xenograft Models of Childhood Cancers$64,694

ZIA · FY2013 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$1,114,868

ZIA · FY2012 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$543,839

ZIA · FY2012 · CA · contact PI

Targeting High-risk Neuroblastoma using high through put siRNA screening$407,878

ZIA · FY2012 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$271,919

ZIA · FY2012 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$135,959

ZIA · FY2012 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$108,768

ZIA · FY2012 · CA · contact PI

Comparative Genomic Hybridization of Neuroblastoma$81,575

ZIA · FY2012 · CA · contact PI

Characterization of Xenograft Models of Childhood Cancers$54,384

ZIA · FY2012 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$1,191,827

ZIA · FY2011 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$581,379

ZIA · FY2011 · CA · contact PI

Targeting High-risk Neuroblastoma using high through put siRNA screening$436,034

ZIA · FY2011 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$290,690

ZIA · FY2011 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$145,345

ZIA · FY2011 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$116,276

ZIA · FY2011 · CA · contact PI

Comparative Genomic Hybridization of Neuroblastoma$87,207

ZIA · FY2011 · CA · contact PI

Characterization of Xenograft Models of Childhood Cancers$58,138

ZIA · FY2011 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$823,779

ZIA · FY2010 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$605,720

ZIA · FY2010 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$363,432

ZIA · FY2010 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$218,059

ZIA · FY2010 · CA · contact PI

Targeting High-risk Neuroblastoma using high through put siRNA screening$121,144

ZIA · FY2010 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$121,144

ZIA · FY2010 · CA · contact PI

Characterization of Xenograft Models of Childhood Cancers$72,687

ZIA · FY2010 · CA · contact PI

Comparative Genomic Hybridization of Neuroblastoma$72,687

ZIA · FY2010 · CA · contact PI

NanoBioSensor Initiative$24,229

ZIA · FY2010 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$986,235

ZIA · FY2009 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$389,303

ZIA · FY2009 · CA · contact PI

Molecular Mechanisms of Drugs$259,536

ZIA · FY2009 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$233,582

ZIA · FY2009 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$129,767

ZIA · FY2009 · CA · contact PI

Identification of Genes for Predicting Prognosis in Pediatric Cancers$129,767

ZIA · FY2009 · CA · contact PI

Targeting High-risk Neuroblastoma using high through put siRNA screening$129,767

ZIA · FY2009 · CA · contact PI

NanoBioSensor Initiative$129,767

ZIA · FY2009 · CA · contact PI

Comparative Genomic Hybridization of Neuroblastoma$77,861

ZIA · FY2009 · CA · contact PI

Characterization of Xenograft Models of Childhood Cancers$77,861

ZIA · FY2009 · CA · contact PI

Gene Expression Profiling of Normal Tissues$51,907

ZIA · FY2009 · CA · contact PI

Identification of Novel Mutations In Pediatric Cancers$453,124

Z01 · FY2008 · CA · contact PI

Micro RNA Profiling in Pediatric Cancers$181,250

Z01 · FY2008 · CA · contact PI

Characterization of FGFR4 mutations in Rhabdomyosarcoma$181,250

Z01 · FY2008 · CA · contact PI

NanoBioSensor Initiative$181,250

Z01 · FY2008 · CA · contact PI

BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA$163,125

Z01 · FY2008 · CA · contact PI